Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
Nature. 2017 Oct 5;550(7674):128-132. doi: 10.1038/nature24028. Epub 2017 Sep 27.
Nature. 2017.
PMID: 28953875
Free PMC article.